Key points from article :
Type 1 diabetes patients may benefit form islet cells transplantation.
Monitored glucose levels continuously in 5 patients that received islet cell transplants in to the liver.
Maintained near normal blood glucose levels without using insulin for about 10 years.
Noted less variability, improvement in time-in-range glucose level and less hypoglycaemia.
These findings will help in getting FDA approval for islet transplantation in US.
Research by University of Miami’s Diabetes Research Institute.
